Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Açın
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1.091,51
-2,30
-0,21%
—1.093,811.096,521.100,221.091,51——
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1.237,98
-16,83
-1,34%
—1.254,811.253,011.253,871.226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1.744,71
-16,40
-0,93%
—1.761,111.764,271.766,881.744,71——
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
—642,58644,87648,48640,18——
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3.260,69
+48,86
+1,52%
—3.211,833.227,213.268,383.226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1.466,80
-7,72
-0,52%
—1.474,521.479,031.481,041.466,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2.397,50
+5,38
+0,22%
—2.392,122.396,952.421,222.382,32——
KYMR:NASDAQ
Kymera Therapeutics Inc
80,71 US$
-0,44%
(-0,36) 1D
80,71 US$
0,00% (0,00)
After hours
Closed: 1 may, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KYMR...
Açın
81,51 US$
High
82,54 US$
Low
79,57 US$
Mkt. cap
6,64 mlrd
Avg. vol.
605,32K
Volume
693,61K
52-wk high
103,00 US$
52-wk low
28,06 US$
EPS
-3,57 US$
Beta
2,29
Shares outstanding
81,64 mln
No. of employees
253
News stories
From sources across the web
About Kymera Therapeutics Inc
CEO-
Employees253
Founded2015
HeadquartersWatertown, Massaçusets, Amerika Birləşmiş Ştatları
Sector-
Websitekymeratx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
iyn 2025
sen 2025
dek 2025
mar 2026
Revenue
11,48 mln
2,76 mln
2,87 mln
34,36 mln
Cost of goods sold
78,39 mln
74,09 mln
83,83 mln
-
Cost of revenue
78,39 mln
74,09 mln
83,83 mln
-
Research and development expenses
-
-
-
98,16 mln
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
17,64 mln
17,34 mln
16,94 mln
20,36 mln
Operating expense
17,64 mln
17,34 mln
16,94 mln
118,52 mln
Total operating expenses
96,03 mln
91,43 mln
100,77 mln
118,52 mln
Operating income
-84,56 mln
-88,67 mln
-97,90 mln
-84,15 mln
Other non operating income
-
-
-
-
EBT including unusual items
-76,61 mln
-82,18 mln
-86,98 mln
-69,23 mln
EBT excluding unusual items
-76,61 mln
-78,32 mln
-86,98 mln
-69,23 mln
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-76,61 mln
-82,18 mln
-86,98 mln
-69,23 mln
Net profit margin
-667,60%
-2.973,05%
-3.030,70%
-201,47%
Earnings per share
-0,95
-0,94
-0,98
-0,71
Interest and investment income
8,05 mln
10,44 mln
11,00 mln
14,98 mln
Interest expense
-108,00K
-98,00K
-90,00K
-61,00K
Net interest expenses
7,94 mln
10,35 mln
10,92 mln
14,92 mln
Depreciation and amortization charges
-
-
-
-
EBITDA
-83,17 mln
-85,82 mln
-97,46 mln
-82,13 mln
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer